Antibiotic linked to liver failure
WASHINGTON, May 19 (UPI) -- The U.S. Food and Drug Administration wants to add a warning label on packaging for an antibiotic that has been linked to liver failure.
An internal FDA memo written by the Division of Drug Risk Evaluation described "profound" liver injury in some patients occurring within the first few days of taking the medication. The memo said that 12 of the cases had few other possible causes, The Wall Street Journal reported.
· Read The Full Tequin Article From United Press International -->
·
Read All Tequin (Gatifloxacin) News Stories -->